THE WHAT? L’Oréal has reportedly appointed Goldman Sachs and Centerview to advise on a potential acquisition of a minority stake in Giorgio Armani, as the Italian fashion house prepares for a possible ownership restructuring.
THE DETAILS According to a report by Mergermarket, L’Oréal has engaged Goldman Sachs and Centerview to evaluate a potential investment in Giorgio Armani. The Armani family’s priority is reportedly to sell an initial 15% stake to one of three companies identified in the late designer’s will: L’Oréal, LVMH or EssilorLuxottica. The sale process is expected to begin in the first quarter of 2027, although an initial public offering remains an alternative under the terms of the will. L’Oréal already holds the Giorgio Armani cosmetics and fragrance licence, which reportedly generates more than €2 billion in annual sales for the French cosmetics group. No transaction has been confirmed, and the potential acquisition remains at an exploratory stage.
THE WHY? A potential investment would strengthen L’Oréal’s strategic relationship with Giorgio Armani and provide an opportunity to secure its long-term interests in one of its most significant luxury cosmetics and fragrance licences. The proposed sale also highlights the importance of ownership structures and succession planning in the luxury sector, particularly where major cosmetics manufacturers depend on long-standing licensing partnerships.
Source: LinkedIn
